Choosing a bioactive recombinant protein — one that is verified active and low in endotoxin — is the difference between a clean dose-response and a confounded one. In cell-based and functional assays, an inactive ligand gives no signal, while a preparation carrying endotoxin can drive an off-target inflammatory response that mimics a real result. This guide covers what to check — activity, endotoxin and expression system — before you commit an experiment to a protein.
Why bioactivity and endotoxin decide your result
Recombinant cytokines and growth factors are only as good as their data. Two failure modes dominate. First, a protein that is misfolded or degraded is inactive: it produces no dose-response, and a stimulation experiment quietly returns nothing. Second — and harder to spot — a preparation contaminated with bacterial endotoxin (lipopolysaccharide, LPS) can trigger NF-κB and pro-inflammatory cytokine signalling on its own, so the effect you attribute to your ligand is really the contaminant. Both are reagent problems, not biology, and both are visible on a good product page before you buy.
When a bioactive recombinant protein result is really endotoxin
This is not hypothetical. In a widely cited study, a commercially available recombinant protein appeared to up-regulate IL-6, IL-8, MCP-1 and other chemokines in human macrophages — yet the response was abolished by inhibiting CD14 and by polymyxin B, and was not reliably blocked by the pathway-specific inhibitor. The authors concluded the effect was driven by low levels of endotoxin in the preparation, not the protein itself (Wakelin et al., Immunobiology 2007). In a separate system, the same protein read as anti-inflammatory when low in endotoxin but pro-inflammatory when endotoxin was high — the contaminant level decided the direction of the result (Persson et al., Chest 2006). The endotoxin value is not a footnote; it can be your entire readout.
What to check on the product page
Three data points, in order. If a page does not show them, treat that as missing information — not as a pass.
1. Verified activity (“Active”)
Look for an explicit Active designation backed by a functional readout — a bioassay, a receptor-binding result, or an ED₅₀ — not just the word “bioactive.” Activity depends on correct folding, so it is tied to the expression system below. Where a page shows activity data, that is the strongest single signal that the ligand will actually stimulate.
2. Stated endotoxin (EU/µg)
For any protein going onto cells — especially immune cells — a stated endotoxin value such as <1 EU/µg is essential. Prefer preparations with a numeric limit on the page and a lot-specific value on the certificate of analysis. Avoid the absolute claim “endotoxin-free”; use the exact figure the manufacturer reports.
3. Defined expression system
E. coli, mammalian, insect/Sf9, or yeast — each affects folding, glycosylation, and typical endotoxin burden. Mammalian and insect systems give glycosylated protein closer to the native molecule; E. coli is economical and often suitable for many cytokines but demands attention to endotoxin. Match the system to what your assay needs, and keep it consistent across a study.
A short checklist before you stimulate
- Activity: is the protein labelled Active with a functional readout on the page?
- Endotoxin: is a numeric value stated (e.g. <1 EU/µg), with a lot CoA available?
- Expression system: is it defined, and appropriate for your assay?
- Dose-response: run one in your own hands to confirm activity before the real experiment.
- One lot: hold a single lot across the study so a change in readout is biology, not a new vial.
- Controls: include a vehicle and, where feasible, a polymyxin-B or endotoxin-inhibitor control to rule out LPS effects.
BioHippo lists functional-grade recombinant cytokines and immune-signalling proteins with activity, endotoxin and expression-system data on the page — see the Active Cytokine & Immune Proteins collection, the wider recombinant proteins & peptides range, and matched ELISA kits for reading the response. For a bespoke format or a lot certificate, use the research services hub.
Frequently asked questions
What endotoxin level is low enough for cell-based assays?
For most cell-based and immune-cell work, aim for a stated endotoxin of <1 EU/µg, and lower for sensitive primary immune cells. Always work from the manufacturer’s stated value and the lot certificate rather than an assumption.
Does “recombinant” mean the protein is active?
No. “Recombinant” describes how the protein was made, not whether it is functional. Rely only on an explicit Active designation backed by a functional or binding readout.
E. coli or mammalian expression — which should I choose?
If your protein needs glycosylation or complex folding for activity, prefer mammalian or insect expression; for many cytokines, well-made E. coli protein is suitable and lower cost, provided endotoxin is controlled. Keep the system consistent within a study.
How do I know my “cytokine effect” is not endotoxin?
Include an endotoxin-neutralising control (for example polymyxin B) or block CD14; if the response disappears, it was endotoxin, not your protein — the approach Wakelin et al. used to expose a contaminated preparation.
References
- Wakelin SJ, Forsythe JLR, Garden OJ, Howie SEM. Commercially available recombinant sonic hedgehog up-regulates Ptc and modulates the cytokine and chemokine expression of human macrophages: an effect mediated by endotoxin contamination? Immunobiology. 2007;213(1):25–38. doi:10.1016/j.imbio.2007.06.006
- Persson C, Subramaniyam D, Stevens T, Janciauskiene S. Do native and polymeric α1-antitrypsin activate human neutrophils in vitro? Chest. 2006;129(6):1683–1692. doi:10.1378/chest.129.6.1683
